BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8928256)

  • 1. [Attitude of pregnant women to prenatal screening].
    Jørgensen FS
    Ugeskr Laeger; 1996 Sep; 158(39):5447-52. PubMed ID: 8928256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes to prenatal screening, diagnosis and research among pregnant women who accept or decline an alpha-fetoprotein test.
    Jørgensen FS
    Prenat Diagn; 1995 May; 15(5):419-29. PubMed ID: 7543997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. User acceptability of an alpha-fetoprotein screening programme.
    Jørgensen FS
    Dan Med Bull; 1995 Feb; 42(1):100-5. PubMed ID: 7537190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome.
    Müller MA; Bleker OP; Bonsel GJ; Bilardo CM
    Prenat Diagn; 2006 Feb; 26(2):105-11. PubMed ID: 16463289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are counsellors' attitudes influencing pregnant women's attitudes and decisions on prenatal screening?
    van den Berg M; Timmermans DR; Kleinveld JH; van Eijk JT; Knol DL; van der Wal G; van Vugt JM
    Prenat Diagn; 2007 Jun; 27(6):518-24. PubMed ID: 17367105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
    Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
    Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The attitude of pregnant women to ultrasound screening. A questionnaire study].
    Skov RV
    Ugeskr Laeger; 1991 Jan; 153(4):283-4. PubMed ID: 1996501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On what grounds do women participate in prenatal screening?
    Santalahti P; Aro AR; Hemminki E; Helenius H; Ryynänen M
    Prenat Diagn; 1998 Feb; 18(2):153-65. PubMed ID: 9516017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding pregnant women's decision making concerning prenatal screening.
    van den Berg M; Timmermans DR; Knol DL; van Eijk JT; de Smit DJ; van Vugt JM; van der Wal G
    Health Psychol; 2008 Jul; 27(4):430-7. PubMed ID: 18643000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes about abortion of women who undergo prenatal diagnosis.
    Kolker A; Burke BM; Phillips JU
    Res Sociol Health Care; 1991; 9():49-73. PubMed ID: 12317576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness and use of prenatal diagnosis among Greek women: a national survey.
    Mavrou A; Metaxotou C; Trichopoulos D
    Prenat Diagn; 1998 Apr; 18(4):349-55. PubMed ID: 9602481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes about prenatal HIV testing in Turkey.
    Ersoy N; Akpinar A
    Nurs Ethics; 2008 Mar; 15(2):222-33. PubMed ID: 18272612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital anomalies: parents' anxiety and women's concerns before prenatal testing and women's opinions towards the risk factors.
    Sahin NH; Gungor I
    J Clin Nurs; 2008 Mar; 17(6):827-36. PubMed ID: 18279286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The maternal self in pregnant women undergoing maternal serum screening.
    Chiang HH; Chao YM; Yuh YS
    J Clin Nurs; 2007 Jun; 16(6):1180-5. PubMed ID: 17518893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The attitude of pregnant women to the possibilities for the prenatal screening and diagnosis of Down's syndrome in the 2nd trimester].
    Dimitrova V; Chernev T; Savova S; Stoianova M
    Akush Ginekol (Sofiia); 2000; 39(1):3-9. PubMed ID: 10826326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population.
    Chan LW; Chau MC; Leung TY; Fung TY; Leung TN; Lau TK
    Prenat Diagn; 2005 Dec; 25(13):1248-52. PubMed ID: 16353273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing women's acceptance of prenatal screening tests.
    Li DK; Karlberg K; Wi S; Norem C
    Prenat Diagn; 2008 Dec; 28(12):1136-43. PubMed ID: 19003797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved prenatal diagnostic possibilities for congenital abnormalities and chromosomal disorders. Advantages and disadvantages of screening and diagnostic methods].
    Nørgaard-Pedersen B; Larsen SO; Larsen JF
    Ugeskr Laeger; 1996 Feb; 158(9):1201-7. PubMed ID: 8644423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K; Sandall J
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.